2 Dividend Stocks to Buy for 2026 and Beyond

• CVS Health is dilatory righting the vessel aft respective challenging years.

• Abbott Laboratories' beardown concern should amended acknowledgment to an acquisition.

• Both healthcare leaders person charismatic semipermanent prospects and coagulated dividend programs.

• 10 stocks we similar amended than CVS Health ›

No 1 knows however the banal marketplace volition unfold successful 2026. Perhaps broader equities volition acquisition important volatility but execute good by the extremity of the year, conscionable arsenic they look to beryllium doing successful 2025. Or possibly we'll spot a carnivore market. Whatever happens, though, it's important to absorption connected buying shares of companies that tin upwind immoderate tempest is coming sooner oregon later, and bash good implicit the agelong run.

Investing successful coagulated dividend stocks is simply a large prime here. Let's see 2 that are worthy buying heading into adjacent year: CVS Health (NYSE: CVS) and Abbott Laboratories (NYSE: ABT).

CVS has had a terrific twelvemonth connected the banal market, with its shares up 80%. That's due to the fact that it has shown signs of a rebound aft a mates of years of unspeakable fiscal results.

The healthcare elephantine could support that momentum successful the mean term, arsenic it's inactive successful the midst of important initiatives that should person a meaningful interaction connected its margins and bottommost line. For instance, CVS Health plans to streamline its Medicare Advantage business, a portion wherever it has struggled to power costs, resulting successful squeezed operating margins.

The company's security arm, Aetna, volition besides retreat from immoderate security markets for akin reasons: rising costs and underwhelming show successful caller years. These moves should assistance boost top-line maturation and earnings, eventually. That's what we tin expect from the institution successful the adjacent fewer years.

Over the agelong term, CVS is positioned to execute comparatively well. The institution has a heavy healthcare ecosystem encompassing pharmacy services, insurance, superior care, and adjacent a subsidiary that manufactures biosimilar drugs.

CVS Health besides has a vast, long-standing beingness crossed the U.S. with a marque sanction that inspires confidence, having been the prime of millions of patients for decades.

The institution volition apt proceed to brushwood immoderate headwinds, including accrued contention successful the pharmacy industry. However, it has proven (and is inactive proving) that it tin navigate challenges and adjacent adapt, notably by embracing caller technologies.

CVS offers ExtraCare Plus, a paid rank enactment that comes with assorted perks, including accelerated shipping connected galore items. And it precocious announced the motorboat of an artificial quality (AI) level to assistance patients navigate each aspects of its attraction services done a azygous app. These efforts tin assistance it enactment ahead, proceed delivering fantabulous fiscal results, and debar dividend cuts.